Plasma cell tumors in transplant patients.
In this issue of Blood, Perry and colleagues describe a form of plasmacytic post-transplant lymphoproliferative disorder (PTLD) that occurs in pediatric organ recipients, is not associated with Epstein-Barr virus (EBV), and is responsive to minimal therapy.(1) Might this represent a separate pathway for PTLD development?